Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia. Murali, I., Kasar, S., Naeem, A., Tyekucheva, S., Khalsa, J. K, Thrash, E. M, Itchaki, G., Livitz, D., Leshchiner, I., Dong, S., & others Blood, The Journal of the American Society of Hematology, 138(1):44–56, American Society of Hematology Washington, DC, 2021.
bibtex   
@article{murali2021activation,
  title={Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia},
  author={Murali, Ishwarya and Kasar, Siddha and Naeem, Aishath and Tyekucheva, Svitlana and Khalsa, Jasneet K and Thrash, Emily M and Itchaki, Gilad and Livitz, Dimitri and Leshchiner, Ignaty and Dong, Shuai and others},
  journal={Blood, The Journal of the American Society of Hematology},
  volume={138},
  number={1},
  pages={44--56},
  year={2021},
  publisher={American Society of Hematology Washington, DC}
}

Downloads: 0